The immune response against early regulatory proteins of simian- and human immunodeficiency virus (SIV, HIV) has been associated with a milder course of infection. Here, we directly compared vaccination with Tat/Rev versus Pol/Gag. Challenge infection with SIVmac32H (pJ5) suggested that vaccination with Tat/Rev induced cellular immune responses that enabled cynomolgus macaques to more efficiently control SIV replication than the vaccine-induced immune responses against Pol/Gag. Vaccination with Tat/Rev resulted in reduced plasma SIV loads compared with control (P=0.058) or Pol/Gag-vaccinated (P=0.089) animals, with undetectable plasma viral loads in two of the four Tat/Rev-vaccinated animals. Therefore, the results warrant further investigation of the early regulatory proteins and their potential for vaccination against HIV.

, , , , , , , , , , , , ,
doi.org/10.1016/S0264-410X(02)00219-0, hdl.handle.net/1765/3872
Vaccine
Erasmus MC: University Medical Center Rotterdam

Stittelaar, K.J, Gruters, R.A, Schutten, M, van Baalen, C.A, van Amerongen, G, Cranage, M.P, … Osterhaus, A.D.M.E. (2002). Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine, 20(23-24), 2921–2927. doi:10.1016/S0264-410X(02)00219-0